ArticleEuropean journal of medical research2025
Clinical characteristics of cervical lymphadenopathy in Kawasaki disease and the generation of related cervical complications: a retrospective cohort study.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Human pathological findings in Kawasaki disease: a narrative review of autopsy and biopsy evidence.Frontiers in immunology · 2026Review
- Incomplete Kawasaki Disease Mimicking Deep Neck Infection: A Case With Tracheal Deviation and Retropharyngeal Edema.Cureus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesCervical lymphadenopathy (CL) is a significant but underexplored feature of Kawasaki disease (KD), especially during its early stages. Although CL is a recognized diagnostic criterion for KD, it is frequently misdiagnosed as bacterial cervical lymphadenitis (BCL). This study aimed to investigate the clinical and imaging characteristics of CL in KD, particularly in cases, where KD initially presents with fever and cervical lymphadenopathy (LKD). The study also focused on differentiating LKD from BCL and examining its association with systemic and cervical complications.
methodsIn this study, 681 KD patients and 101 BCL patients hospitalized at the Yuying Children's Hospital affiliated with Wenzhou Medical University from January 1, 2021, to October 1, 2023, were enrolled. Among the KD patients, 403 exhibited cervical lymphadenopathy, including 86 who presented only with fever and cervical lymphadenopathy upon admission (LKD group), 317 who displayed typical features of cervical lymphadenopathy (Other KD group), and 243 who did not exhibit cervical lymphadenopathy. Demographic, clinical, laboratory, and imaging data were compared across these groups to identify distinguishing characteristics and potential complications.
resultsThe findings indicated that patients with CL in KD were younger than those with BCL, experienced a longer duration of fever prior to treatment, and exhibited more severe inflammatory responses and liver abnormalities. KD patients with enlarged cervical lymph nodes were more likely to exhibit systemic involvement. Imaging studies revealed bilateral lymph node enlargement without liquefaction in KD, which contrasts with the abscess formation commonly observed in BCL. Compared to KD patients without lymphadenopathy, those with CL were older, more likely to present with conjunctival congestion, had higher neutrophil ratios, elevated liver damage markers, an increased rate of intravenous immunoglobulin (IVIG) resistance, and a higher incidence of KD shock syndrome (KDSS). Among these, LKD patients were older, nearly all reported neck pain, had a higher referral rate, elevated neutrophil counts and C-reactive protein (CRP) levels, and a higher prevalence of cervical complications, such as atlantoaxial subluxation and parotitis. Ultrasound examinations of cervical lymph nodes showed that the LKD group had larger diameters of enlarged lymph nodes, with the largest lymph node frequently found in the Level II region.
conclusionsIVIG resistance and KDSS are more prevalent among patients with cervical lymph node enlargement in Kawasaki disease compared to those without lymph node involvement. When cervical B-ultrasonography reveals bilateral multiple lymph nodes in Level II regions, without liquefaction or significant abscess formation, clinicians should be vigilant for the possibility of Kawasaki disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.